Sanofi Negotiating Exclusively With CD&R for Opella 50% Stake Sale
SNY is negotiating with CD&R to sell a 50% stake in its consumer healthcare business, Opella.
| Ticker |
Sentiment |
Impact |
|
KVUE
|
Neutral
|
7 %
|
|
HLN
|
Neutral
|
7 %
|
|
GSK
|
Neutral
|
28 %
|
|
PFE
|
Neutral
|
21 %
|
|
SNY
|
Somewhat Bullish
|
68 %
|
